Colgate-Palmolive’s adjusted earnings rose 7% to $0.97 a share in the third quarter, exceeding analyst estimates of 93 cents and 92 cents. Lululemon, by contrast, expects third-quarter revenue to fall 10% to 11%.
That contrast favors the toothpaste maker on near-term trading momentum. It does not make Colgate the financially stronger company on every measure: its debt-to-equity ratio was 158.4x in December 2025, compared with approximately 0.4x for Lululemon in February 2026.
The detail that matters is therefore not a simple contest between a safe stock and a risky one. It is a comparison between steady demand with substantial leverage and weaker apparel sales with a cleaner balance sheet.
Colgate’s improving quarter
Third-quarter net sales increased 4.6%, while organic sales rose 3.6%. Lower private-label pet food sales reduced the organic figure by 0.2%.
GAAP earnings increased 3% to $0.94 a share. GAAP gross margin improved 80 basis points to 60.2%, and Base Business gross margin rose 90 basis points to 60.3%.
Operating cash flow reached $2,913 million during the first nine months of 2026. Colgate also reported a fourth consecutive quarter of improving worldwide volume growth.
Its global year-to-date market shares were 41.4% in toothpaste and 33.1% in manual toothbrushes. Sales increased in all four product categories and four of five divisions.
North America was the weak geographic exception, with net sales down 1.7%. Hill’s Pet Nutrition grew 5.6%.
Management narrowed expected full-year net sales growth to 4% to 5%, replacing a 2% to 6% range. Its adjusted EPS growth forecast increased to 5% to 7% from mid-single digits, and it now expects gross margin to rise on both a GAAP and adjusted basis.
Shares rose 3.5% to $96.45 in premarket trading after the report.
What the defensive label leaves out
Colgate sells oral, personal and home-care products plus pet nutrition in more than 200 countries. Two-thirds of revenue comes from outside the United States, giving the company geographic breadth but exposing it to geopolitical and currency conditions.
Its FY 2025 revenue was close to $20.4 billion, up approximately 1.4%. Net income was roughly $2.1 billion and free cash flow about $3.6 billion.
The annual net margin, however, fell to nearly 10.5% from 14.4% in FY 2024. The current ratio was approximately 0.8x at December 2025, alongside that 158.4x debt-to-equity figure.
Walmart accounted for nearly 11% of sales in 2025, creating customer-concentration risk. Competition from global peers and private-label products, talc litigation and ingredient regulation add further exposure.
India illustrates the margin tension. September-quarter revenue increased 12.2%. Volumes grew by high single digits, with premium products and MaxFresh helping sales. Higher brand investment and competition nevertheless pressured profitability, with Haleon expanding capacity behind Sensodyne and Parodontax.
Colgate is also exploring a sale of Softsoap, Irish Spring and Speed Stick. The brands could together bring more than $1 billion.
Lululemon’s weaker sales, stronger liquidity
Lululemon’s annual report presents a different profile. FY 2025 revenue approached $11.1 billion, growing approximately 4.9%, with net income of roughly $1.6 billion and a net margin around 14.2%.
Free cash flow was close to $921.7 million. Its current ratio stood at 2.3x, substantially above Colgate’s, and debt-to-equity was approximately 0.4x.
The company operated more than 850 company-owned and licensed locations as of February 2026, including newly acquired operations in Mexico.
Its immediate problem is demand. Second-quarter revenue declined 5% year over year after excluding currency translation for the period ending August 2. Management projected a 5% to 7% revenue decline for the year.
Premium athletic clothing is more exposed to discretionary spending and changing fashions than toothpaste. Limited patent protection leaves products open to lower-priced imitators, while concentrated Asian manufacturing creates supply-chain risk.
Corporate uncertainty compounds those pressures. Lululemon’s CEO departed in early 2026, and its founder has pursued a proxy contest.
Valuation does not automatically settle the argument either: Lululemon trades at a lower forward price-to-earnings ratio based on expected earnings.
One historical marker sits firmly in Colgate’s favor: uninterrupted dividends began in 1895, and annual increases have now run for 63 straight years.
Sources
- Affle to acquire Perion, to scale its CPCU business across Developed markets
- Colgate-Palmolive
- Colgate-Palmolive Announces 3rd Quarter 2026 Results
- Colgate-Palmolive Q3 2026 earnings beat estimates, outlook raised
- Colgate-Palmolive vs. Lululemon Athletica: Which Consumer Goods Stock Is a Better Buy in 2026? | The Motley Fool
- Colgate-Palmolive India stock faces pressure as ad costs rise
Photo: Beyond My Ken (CC BY-SA 4.0)





